Summit Therapeutics Files For Mixed Shelf Offering; Size Not Disclosed

Benzinga Newsdesk www.benzinga.com Neutral 93.1%

Neg 0% Neu 93.1% Pos 0%

https://www.sec.gov/Archives/edgar/data/1599298/000119312526263861/d124326ds3asr.htm

Comments

No comments yet. Be the first!